000 01423 a2200397 4500
005 20250513040253.0
264 0 _c19930610
008 199306s 0 0 eng d
022 _a0885-4505
024 7 _a10.1006/bmmb.1993.1022
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSpence, W C
245 0 0 _aNeonatal screening for cystic fibrosis: addition of molecular diagnostics to increase specificity.
_h[electronic resource]
260 _bBiochemical medicine and metabolic biology
_cApr 1993
300 _a200-11 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aCystic Fibrosis
_xdiagnosis
650 0 4 _aCystic Fibrosis Transmembrane Conductance Regulator
650 0 4 _aDNA
_xanalysis
650 0 4 _aExons
650 0 4 _aGene Deletion
650 0 4 _aHumans
650 0 4 _aInfant, Newborn
650 0 4 _aMembrane Proteins
_xgenetics
650 0 4 _aMutation
650 0 4 _aNeonatal Screening
650 0 4 _aPennsylvania
_xepidemiology
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aPolymorphism, Restriction Fragment Length
650 0 4 _aTrypsinogen
_xblood
700 1 _aPaulus-Thomas, J
700 1 _aOrenstein, D M
700 1 _aNaylor, E W
773 0 _tBiochemical medicine and metabolic biology
_gvol. 49
_gno. 2
_gp. 200-11
856 4 0 _uhttps://doi.org/10.1006/bmmb.1993.1022
_zAvailable from publisher's website
999 _c7682902
_d7682902